These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15082668)

  • 1. Compliance with recommendations for lipid management among patients with type 2 diabetes in an academic family practice.
    Putzer G; Roetzheim R; Ramirez AM; Sneed K; Brownlee HJ; Campbell RJ
    J Am Board Fam Pract; 2004; 17(2):101-7. PubMed ID: 15082668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attainment of goals from national guidelines among persons with type 2 diabetes: a cohort study in an academic family medicine setting.
    Kirk JK; Huber KR; Clinch CR
    N C Med J; 2005; 66(6):415-9. PubMed ID: 16438097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial).
    Meyers CD; McCarren M; Wong ND; Abraira C; Duckworth WC; Kashyap ML;
    Am J Cardiol; 2006 Jul; 98(1):63-5. PubMed ID: 16784922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with national guidelines in patients with diabetes in a family practice clinic.
    Kirk JK; Poirier JE; Mattox MG; Thomas PM; Michielutte R
    Pharmacotherapy; 2002 Dec; 22(12):1541-6. PubMed ID: 12495165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
    Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
    Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Weiss R; Harder M; Rowe J
    Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
    Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
    J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)].
    Föger B; Patsch JR
    Wien Klin Wochenschr; 2011 Jan; 123(1-2):21-7. PubMed ID: 21165704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.
    Boronat M; García-Cantón C; López-Ríos L; Quevedo V; Lorenzo DL; Batista F; Riaño M; Nóvoa FJ
    Diab Vasc Dis Res; 2014 Jan; 11(1):53-9. PubMed ID: 24254975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-high-density lipoprotein cholesterol reporting and goal attainment in primary care.
    Virani SS; Wang D; Woodard LD; Chitwood SS; Landrum CR; Zieve FJ; Ballantyne CM; Petersen LA
    J Clin Lipidol; 2012; 6(6):545-52. PubMed ID: 23312050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of measuring non-HDL cholesterol in type 2 diabetes patients.
    Ram N; Ahmed B; Hashmi F; Jabbar A
    J Pak Med Assoc; 2014 Feb; 64(2):124-8. PubMed ID: 24640797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers.
    Mazzolini TA; Irons BK; Schell EC; Seifert CF
    J Manag Care Pharm; 2005; 11(9):763-71. PubMed ID: 16300420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular events in patients at optimal values for combined lipid parameters.
    Stanek EJ; Sarawate C; Willey VJ; Charland SL; Cziraky MJ
    Curr Med Res Opin; 2007 Mar; 23(3):553-63. PubMed ID: 17357251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.